Top Markets
Coin of the day
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
Classement en actions #28150
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Prix de l'action
$1.40
Dernière synchronisation: 2026-08-18
Capitalisation boursière
$28.25M
Changement (1 jour)
0.00%
Changement (1 an)
536.36%
Pays
IL
Échange Raphael Pharmaceutical Inc. (RAPH)

Catégorie

Ratio P/B pour Raphael Pharmaceutical Inc. (RAPH)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Raphael Pharmaceutical Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Raphael Pharmaceutical Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes